Alpa Laboratories Ltd (ALPA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Syschem (India)

BDH Industries

Genesis IBRC

Auro Labs.

Panch.Organics

Coral Labs.

Ambalal Sarabhai

Alpa Laboratorie

Pharmaids Pharma

Balaxi Pharma

Natural Capsules

Why is Alpa Laboratories Ltd ?

Poor long term growth as Operating profit has grown by an annual rate -206.03% of over the last 5 years

Negative results in Sep 25

PBT LESS OI(Q) At Rs -2.95 cr has Fallen at -619.8% (vs previous 4Q average)
PAT(Q) At Rs 0.11 cr has Fallen at -98.3% (vs previous 4Q average)
ROCE(HY) Lowest at 12.57%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -30.28%, its profits have fallen by -10.4%

Below par performance in long term as well as near term

Along with generating -30.28% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alpa Laboratorie for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Alpa Laboratorie

-32.02%

-0.70

43.31%

Sensex

4.56%

0.37

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.41%

EBIT Growth (5y)

-206.03%

EBIT to Interest (avg)

4.90

Debt to EBITDA (avg)

2.04

Net Debt to Equity (avg)

-0.76

Sales to Capital Employed (avg)

0.74

Tax Ratio

18.37%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.35%

ROCE (avg)

9.98%

ROE (avg)

10.32%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.97

EV to EBIT

-11.79

EV to EBITDA

-38.08

EV to Capital Employed

0.86

EV to Sales

0.34

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.29%

ROE (Latest)

10.18%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET SALES(9M)

At Rs 85.29 cr has Grown at 21.86%

DEBTORS TURNOVER RATIO(HY)

Highest at 3.03 times

-15What is not working for the Company

PBT LESS OI(Q)

At Rs -2.95 cr has Fallen at -619.8% (vs previous 4Q average

PAT(Q)

At Rs 0.11 cr has Fallen at -98.3% (vs previous 4Q average

ROCE(HY)

Lowest at 12.57%

PBDIT(Q)

Lowest at Rs -2.24 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -8.53%

NON-OPERATING INCOME(Q)

is 2,781.82 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Alpa Laboratorie

Net Sales - Nine Monthly

At Rs 85.29 cr has Grown at 21.86%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly

Highest at 3.03 times

in the last five half yearly periods

MOJO Watch

Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Alpa Laboratorie

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -2.95 cr has Fallen at -619.8% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 0.57 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 0.11 cr has Fallen at -98.3% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 6.56 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Lowest at Rs -2.24 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Lowest at -8.53%

in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at Rs -2.95 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly

is 2,781.82 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT